FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/083810 [Registered on: 01/04/2025] Trial Registered Prospectively
Last Modified On: 29/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   To study efficacy of Rohitak Abhaya Kwath in the management of Non Alcoholic Fatty Liver Disease 
Scientific Title of Study   A clinical study on the efficacy of Rohitak Abhaya Kwath in the management of Non Alcoholic Fatty Liver Disease 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Neelim Shyam Bharali 
Designation  PG Scholar 
Affiliation  Govt Ayurvedic College & Hospital Guwahati 
Address  Dept of Kayachikitsa Govt Ayurvedic College and Hospital Guwahati

Kamrup
ASSAM
781014
India 
Phone  9954522422  
Fax    
Email  drneelim7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shyamanta Kalita 
Designation  Associate Professor & Guide 
Affiliation  Govt Ayurvedic College & Hospital Guwahati 
Address  Dept of Kayachikitsa Govt Ayurvedic College and Hospital Guwahati

Kamrup
ASSAM
781014
India 
Phone  9707186463  
Fax    
Email  kalitashyamanta108@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Shyamanta Kalita 
Designation  Associate Professor & Guide 
Affiliation  Govt Ayurvedic College & Hospital Guwahati 
Address  Dept of Kayachikitsa Govt Ayurvedic College and Hospital Guwahati

Kamrup
ASSAM
781014
India 
Phone  9707186463  
Fax    
Email  kalitashyamanta108@gmail.com  
 
Source of Monetary or Material Support  
Govt Ayurvedic College and Hospital Guwahati 781014 
 
Primary Sponsor  
Name  Dr Neelim Shyam Bharali 
Address  Govt. Ayurvedic College and Hospital Jalukbari Guwahati 781014 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Neelim Shyam Bharali  Govt Ayurvedic College & Hospital Guwahati-14  OPD & IPD of Dept. of Kayachikitsa, Govt Ayurvedic College and Hospital Jalukbari Guwahati-14
Kamrup
ASSAM 
9954522422

drneelim7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute Ethics Committee, Govt Ayurvedic College and Hospital, Jalukbari, Guwahati  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K760||Fatty (change of) liver, not elsewhere classified. Ayurveda Condition: YAKRUDDALYUDARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator Arm (Non Ayurveda)-Ursodeoxycholic AcidDose: 300 mg BiD Duration: 45 days Route: Oral
2Intervention ArmDrugClassical(1) Medicine Name: Rohitak Abhaya Kwath, Reference: Chakradatta Chapter 38, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 48(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1. Patients between 18 to 70 years of age irrespective of the sex.
2. Subjects having complaints of indigestion, pain abdomen, anorexia, fatigue,
nausea and fulfilling the criteria of diagnosis.
3. Non alcoholic fatty liver- Grade I, Grade II and Grade III 
 
ExclusionCriteria 
Details  1. Subjects below 18 years more than 70 years.
2. Pregnancy and lactating mother
3. Any cardiac problem
4. Psychiatric disorders.
5. Stomach ulcer
6. Cancer patients
7. Surgical intervention if any.
8. CLD patients with Ascites 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To assess the effectiveness of Rohitak Abhaya Kwath in the management of
symptomatology of NAFLD 
45 Days 
 
Secondary Outcome  
Outcome  TimePoints 
To compare the efficacy of Rohitak Abhaya Kwath with Ursodeoxycholic Acid on LFT, USG WA and Lipid Profile  15th, 30th and 45th day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   12/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
This is a clinical study of Rohtak Abhaya Keats in management of Non Alcoholic Fatty Liver Disease. This study is done as a mandatory Post graduation thesis work. Total number of 60 patients will be studied for 45 days each.
 
Close